This inventor holds 8 USPTO granted patents and 1 EPO patent. Top assignees: Diagen Corporation, Tanox, Inc., Genentech, Inc.. Active years: 2001-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3 
3 out of 31 
1 out of 3,300 
Years Active: 2001-2009
Title: Samuil R Umansky: Innovator in Apoptosis-Related Research
Introduction
Samuil R Umansky is a notable inventor based in Richmond, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of apoptosis-related peptides. With a total of 8 patents to his name, Umansky's work has implications for therapeutic applications in various diseases.
Latest Patents
Umansky's latest patents include a family of genes encoding apoptosis-related peptides, which are crucial for understanding cell death mechanisms. One of his notable inventions involves an isolated polynucleotide that is at least 60% homologous to specific sequences, encoding a SARP polypeptide. This invention also encompasses vectors that include polynucleotide sequences and host cells transformed with these sequences. Additionally, he has developed antibodies specific for SARP and methods for using these polynucleotides and antibodies in diagnostic and therapeutic applications. Another significant patent focuses on therapeutic uses of antibodies and polynucleotides related to SARP, particularly in treating diseases associated with SARP expression regulation, including cancers. Furthermore, he has created anti-apoptotic compositions containing lysophosphatidic acids, which have potential applications in drug development and wound healing.
Career Highlights
Throughout his career, Umansky has worked with various companies, including Tanox, Inc. and Diagen Corporation. His innovative research has positioned him as a key figure in the biotechnology sector, contributing to advancements in therapeutic methods.
Collaborations
Umansky has collaborated with notable professionals in his field, including Hovsep S Melkonyan and Anatoly V Lichtenstein. These collaborations have further enriched his research and development efforts.
Conclusion
Samuil R Umansky's contributions to the field of biotechnology, particularly in apoptosis-related research, have made a significant impact. His innovative patents and collaborations highlight his role as a leading inventor in this important area of study.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile